Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5269268
Max Phase: Preclinical
Molecular Formula: C38H12Br4N4O8S2
Molecular Weight: 1036.28
Associated Items:
ID: ALA5269268
Max Phase: Preclinical
Molecular Formula: C38H12Br4N4O8S2
Molecular Weight: 1036.28
Associated Items:
Canonical SMILES: O=C1c2ccc3c4c(ccc(c24)C(=O)N1c1nc(-c2cc4cc(Br)cc(Br)c4oc2=O)cs1)C(=O)N(c1nc(-c2cc4cc(Br)cc(Br)c4oc2=O)cs1)C3=O
Standard InChI: InChI=1S/C38H12Br4N4O8S2/c39-15-5-13-7-21(35(51)53-29(13)23(41)9-15)25-11-55-37(43-25)45-31(47)17-1-2-18-28-20(4-3-19(27(17)28)33(45)49)34(50)46(32(18)48)38-44-26(12-56-38)22-8-14-6-16(40)10-24(42)30(14)54-36(22)52/h1-12H
Standard InChI Key: WQFCIHOOYOCXOG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1036.28 | Molecular Weight (Monoisotopic): 1031.6830 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Tomczyk MD, Walczak KZ.. (2018) l,8-Naphthalimide based DNA intercalators and anticancer agents. A systematic review from 2007 to 2017., 159 [PMID:30312931] [10.1016/j.ejmech.2018.09.055] |
Source(1):